CA2358479C
(fr)
*
|
1996-05-04 |
2004-07-13 |
Yuhan Corporation |
4-substitue-2-(4-fluorophenylamino)-5,6 dimethylpyrimidine
|
US6252076B1
(en)
|
1996-05-04 |
2001-06-26 |
Yuhan Corporation |
Process for preparation of pyrimidine derivatives
|
HU226752B1
(en)
*
|
1996-10-29 |
2009-09-28 |
Yuhan Corp |
Process for preparation of pyrimidine derivatives
|
DK0976745T3
(da)
*
|
1997-03-26 |
2003-10-27 |
Taisho Pharmaceutical Co Ltd |
4-tetrahydropyridylpyrimidinderivat
|
IN188411B
(fr)
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
CA2296014A1
(fr)
*
|
1997-07-03 |
1999-01-14 |
Frank W. Hobbs |
Heterocycles aryl- et arylamino-substitues utilises comme antagonistes de l'hormone corticotrope
|
ES2274634T3
(es)
|
1998-08-29 |
2007-05-16 |
Astrazeneca Ab |
Compuestos de pirimidina.
|
ES2270612T3
(es)
|
1998-08-29 |
2007-04-01 |
Astrazeneca Ab |
Compuestos de pirimidina.
|
KR100272471B1
(ko)
*
|
1998-11-17 |
2000-11-15 |
김선진 |
신규의 피리미딘 유도체 및 그의 제조방법
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
WO2000042025A1
(fr)
*
|
1999-01-14 |
2000-07-20 |
Meiji Seika Kaisha, Ltd. |
Inhibiteurs de poly(adp-ribose) polymerase consistant en des derives de pyrimidine
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
US7365047B1
(en)
|
1999-09-28 |
2008-04-29 |
The Regents Of The University Of California |
Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
|
MXPA02003436A
(es)
|
1999-10-07 |
2002-08-20 |
Amgen Inc |
Inhibidores de triazina cinasa.
|
CA2400447C
(fr)
|
2000-02-17 |
2008-04-22 |
Amgen Inc. |
Inhibiteurs de kinases
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
HU230574B1
(hu)
|
2000-12-21 |
2023-11-28 |
Novartis Ag |
Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
TW200302728A
(en)
|
2002-02-01 |
2003-08-16 |
Novartis Ag |
Substituted amines as IgE inhibitors
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
JP2005524672A
(ja)
|
2002-03-09 |
2005-08-18 |
アストラゼネカ アクチボラグ |
Cdk阻害活性を有するイミダゾリル置換ピリミジン誘導体
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2004012659A2
(fr)
*
|
2002-08-01 |
2004-02-12 |
Nitromed, Inc. |
Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
US20070161637A1
(en)
*
|
2003-07-22 |
2007-07-12 |
Neurogen Corporation |
Substituted pyridin-2-ylamine analogues
|
EP1911754B1
(fr)
|
2003-08-13 |
2013-10-09 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de peptidase dipeptidyl
|
BRPI0414238A
(pt)
*
|
2003-09-09 |
2006-10-31 |
Ono Pharmaceutical Co |
antagonistas de crf e compostos heterobicìclicos
|
CN101361738A
(zh)
|
2003-11-03 |
2009-02-11 |
阿斯利康(瑞典)有限公司 |
治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
AU2005280738B2
(en)
|
2004-09-03 |
2010-11-25 |
Yuhan Corporation |
Pyrrolo(3,2-c)pyridine derivatives and processes for the preparation thereof
|
ES2426920T3
(es)
|
2004-09-03 |
2013-10-25 |
Yuhan Corporation |
Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
|
KR100958829B1
(ko)
|
2004-09-03 |
2010-05-25 |
주식회사유한양행 |
피롤로[2,3-c]피리딘 유도체 및 그의 제조방법
|
US20060165797A1
(en)
*
|
2005-01-12 |
2006-07-27 |
Pozen Inc. |
Dosage form for treating gastrointestinal disorders
|
US7803817B2
(en)
*
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7981908B2
(en)
*
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
AU2006296386A1
(en)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
US7776873B2
(en)
|
2005-12-01 |
2010-08-17 |
Yuhan Corporation |
Method for treating damage to gastric mucosa
|
US20070154542A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
CN101460154B
(zh)
|
2006-04-04 |
2015-07-01 |
Kg艾克维泽生公司 |
包含抗血小板剂和抑酸剂的口服剂型
|
CN101516891B
(zh)
|
2006-07-06 |
2013-06-05 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的二氢噻吩并嘧啶
|
RU2481336C2
(ru)
*
|
2006-07-06 |
2013-05-10 |
Эррэй Биофарма Инк. |
Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт
|
CN101511842B
(zh)
|
2006-07-06 |
2012-10-31 |
阵列生物制药公司 |
作为akt蛋白激酶抑制剂的二氢呋喃并嘧啶
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
PL2046334T3
(pl)
*
|
2006-07-25 |
2015-02-27 |
Vecta Ltd |
Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
|
EP2086543A2
(fr)
|
2006-10-27 |
2009-08-12 |
The Curators of the University of Missouri |
Compositions comprenant des agents d'inhibition de la pompe à protons labiles d'acide, au moins un autre agent pharmaceutiquement actif et leurs procédés d'utilisation
|
CA2673536A1
(fr)
*
|
2006-12-22 |
2008-07-03 |
Yuhan Corporation |
Dispersion solide contenant du revaprazane et procede d'elaboration
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
RU2486181C2
(ru)
|
2007-07-05 |
2013-06-27 |
Эррэй Биофарма Инк. |
Пиримидилциклопентаны как ингибиторы акт-протеинкиназ
|
BRPI0813993A2
(pt)
*
|
2007-07-05 |
2015-06-16 |
Array Biopharma Inc |
Ciclopentanos de pirimidila como inibidores de proteína quinase akt
|
NZ586346A
(en)
*
|
2008-01-09 |
2012-02-24 |
Array Biopharma Inc |
Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
NZ586720A
(en)
*
|
2008-01-09 |
2012-11-30 |
Array Biopharma Inc |
Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
|
KR20110079641A
(ko)
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
AU2010263304A1
(en)
|
2009-06-25 |
2012-02-02 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an NSAID-associated ulcer
|
CA2766524A1
(fr)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Procede de traitement d'un patient necessitant une therapie a l'aspirine
|
CN102470126A
(zh)
*
|
2009-07-09 |
2012-05-23 |
拉夸里亚创药株式会社 |
用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
|
KR101739815B1
(ko)
|
2010-12-01 |
2017-05-26 |
주식회사유한양행 |
레바프라잔 또는 그의 염을 함유하는 주사용 액제 조성물
|
KR101730865B1
(ko)
*
|
2011-02-11 |
2017-04-27 |
주식회사유한양행 |
레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
|
JP5980236B2
(ja)
*
|
2011-02-25 |
2016-08-31 |
ユーハン・コーポレイションYUHAN Corporation |
ジアミノピリミジン誘導体及びその製造方法
|
KR20140022053A
(ko)
|
2011-04-01 |
2014-02-21 |
제넨테크, 인크. |
Akt 및 mek 억제제 화합물의 조합물, 및 사용 방법
|
CN103857395A
(zh)
|
2011-04-01 |
2014-06-11 |
基因泰克公司 |
Akt抑制剂化合物和阿比特龙的组合及使用方法
|
CN102863423B
(zh)
*
|
2011-07-04 |
2014-09-17 |
天津药物研究院 |
一种制备异喹啉基取代的嘧啶衍生物的方法
|
EP2797600A4
(fr)
|
2011-12-28 |
2015-09-16 |
Pozen Inc |
Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
|
WO2014060908A1
(fr)
|
2012-10-17 |
2014-04-24 |
Lupin Limited |
Procédé amélioré pour la préparation de chlorhydrate de révaprazan
|
JP6412503B2
(ja)
|
2012-11-21 |
2018-10-24 |
ピーティーシー セラピューティクス, インコーポレイテッド |
置換逆ピリミジンBmi−1阻害剤
|
CN102993173B
(zh)
*
|
2012-12-28 |
2014-09-03 |
山东大学 |
洛氟普啶的制备方法
|
KR101657616B1
(ko)
*
|
2013-05-24 |
2016-09-19 |
주식회사유한양행 |
피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
|
WO2015012210A1
(fr)
|
2013-07-23 |
2015-01-29 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
Composé cyclique hétérocondensé
|
WO2015030847A1
(fr)
*
|
2013-08-30 |
2015-03-05 |
Ptc Therapeutics, Inc. |
Inhibiteurs de bmi-1 à base de pyrimidines substituées
|
CN104903312B
(zh)
*
|
2013-10-07 |
2019-01-29 |
卡德门企业有限公司 |
Rho激酶抑制剂
|
EP3071553A4
(fr)
|
2013-11-21 |
2017-08-02 |
PTC Therapeutics, Inc. |
Inhibiteurs de bmi-1 à base de pyridine et de pyrazine substituées
|
CN105601611A
(zh)
*
|
2014-11-19 |
2016-05-25 |
江苏天士力帝益药业有限公司 |
一种盐酸洛氟普啶多晶型物及其制备方法
|
CN105669642B
(zh)
|
2014-11-19 |
2020-06-09 |
江苏天士力帝益药业有限公司 |
一种盐酸洛氟普啶的制备方法
|
EP4008319A1
(fr)
|
2015-11-25 |
2022-06-08 |
Axsome Therapeutics, Inc. |
Compositions pharmaceutiques contenant du méloxicam
|
CN105399727A
(zh)
*
|
2015-12-02 |
2016-03-16 |
芷威(上海)化学科技有限公司 |
盐酸瑞伐拉赞新结晶形态
|
CN106995432A
(zh)
*
|
2016-01-25 |
2017-08-01 |
广东华南药业集团有限公司 |
一种瑞普拉生无水合物晶型及其制备方法和用途
|
CN106995431A
(zh)
*
|
2016-01-25 |
2017-08-01 |
广东华南药业集团有限公司 |
一种瑞普拉生水合物晶型及其制备方法和用途
|
KR20190122659A
(ko)
|
2017-01-04 |
2019-10-30 |
액섬 테라퓨틱스, 인크. |
멜록시캄을 포함하는 약학적 조성물
|
WO2018209150A1
(fr)
|
2017-05-10 |
2018-11-15 |
Axsome Therapeutics, Inc. |
Compositions pharmaceutiques contenant du méloxicam
|